Arcutis Biotherapeutics, Inc. ($ARQT)
Burnett Patrick โ Reporting Person's title: EVP, Chief Medical Officer
Shares
77,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 24, 2026
EPS:Est: 0.02
Feb 25, 2026
EPS:Est: 0.03
Revenue:Est: $113.03M
Transaction Details
| Insider | Burnett Patrick |
|---|---|
| Title | Reporting Person's title: EVP, Chief Medical Officer |
| Transaction Date | Feb 27, 2026 |
| Expiration Date | Feb 27, 2036 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Stock Option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Mar 3, 2026 |
| Shares Purchased | 77,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 77,000 |
| Derivative | Derivative |
| Accession Number | 0001628280-26-014324 |
| Document | View SEC Filing |